ClearPoint Neuro, Inc.CLPTNASDAQ
Loading
EV to Sales: Premium ValuationElevated
Percentile Rank57
3Y CAGR+5.5%
5Y CAGR-11.5%
Studio
Year-over-Year Change

Enterprise value to sales ratio

3Y CAGR
+5.5%/yr
vs +40.2%/yr prior
5Y CAGR
-11.5%/yr
Recent acceleration
Acceleration
-34.7pp
Decelerating
Percentile
P57
Within normal range
vs 5Y Ago
0.5x
Contraction
Streak
1 yr
Consecutive declineElevated
PeriodValueYoY Change
202510.81-15.0%
202412.72+92.9%
20236.59-28.4%
20229.21-21.4%
202111.71-41.3%
202019.94+273.4%
20195.34+124.0%
20182.38+4.1%
20172.29+25.0%
20161.83-